| ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 29
| Issue : 2 | Page : 337-340 |
|
|
Evaluation of interleukin-6 and C-reactive protein in patients with breast cancer at Menoufia University Hospitals
Gehan K El Saeed, Dalia M Hosny Abou-elela, Mona T Ahmed El-Gendy
Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
Correspondence Address:
Mona T Ahmed El-Gendy
Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Gamal Abdel Nasser Street, Shebin Al-Kom, Al-Menoufia, 32511
Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1110-2098.192447
|
|
|
Objectives:
The aim of this study was to determine the serum level of interleukin-6 (IL-6) and C-reactive protein (CRP) in patients with breast cancer and to correlate them with the staging of the disease.
Background:
Breast cancer is a disease that continues to plague women. IL-6 and CRP are found to be elevated in various inflammatory and malignant diseases, and their levels are found to correlate with the extent of the disease.
Patients and methods:
A total of 39 female patients with breast cancer were identified for the study. Serum level of IL-6 was assessed with enzyme-linked immunosorbent assay, and CRP was measured by means of immunoturbidimetry. The patients were classified into six groups on the basis of the pathological Tumor-Node-Metastasis (TNM) system. Statistical analyses of the data were then processed.
Results:
Increase in cancer invasion and staging are generally associated with increase in preoperative serum IL-6 and CRP level. IL-6 and CRP level correlate with lymph node metastasis (P > 0.001) and distant metastasis (P > 0.001). Serum IL-6 and CRP level correlate with TNM staging (P > 0.001).
Conclusion:
The levels of IL-6 and CRP have a positive correlation with the TNM staging system of breast cancer. Hence, IL-6 and CRP could be used as parameters to assess the prognosis of breast cancer patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
